Medtronic has received 510(k) approval from the FDA for its Aquamantys 3 BSC 9.1S Bipolar Sealer with Cutting, a new addition to company's orthopedic portfolio. The BSC 9.1S Bipolar Sealer with Cutting combines hemostatic sealing capabilities for soft tissue and bone and monopolar cutting functionality in a single device. It is designed to reduce blood loss and maintain patient hemoglobin levels during orthopedic procedures.
More Articles on Orthopedic Devices:
DJO Surgical Signs Agreement with University of Utah for Prosthetic Implants
NuVasive Announces $154.4M Revenue for 2Q, Up 16.1%
MEDICREA Sales Increase 32% Over First Half of 2012